Skip to content

Bio-Techne

NASDAQ: TECH · USD

Bio-Techne cash flow and EPS—

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$62.615M
Bio-Techne capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2011 Q18.34% · $1.052MUnavailable15.37% · $1.94M76.29% · $9.629MUnavailable100% · $12.621M
FY 2011 Q26.65% · $0.713MUnavailable0% · $0M93.35% · $10.011MUnavailable100% · $10.724M
FY 2011 Q35.58% · $0.592MUnavailable0% · $0M94.42% · $10.022MUnavailable100% · $10.614M
FY 2011 Q411.26% · $1.273MUnavailable0% · $0M88.74% · $10.029MUnavailable100% · $11.302M
FY 2012 Q15.03% · $1.096MUnavailable48.97% · $10.675M46% · $10.026MUnavailable100% · $21.797M
FY 2012 Q211.21% · $2.201MUnavailable36.02% · $7.073M52.77% · $10.361MUnavailable100% · $19.635M
FY 2012 Q310.28% · $1.587MUnavailable22.89% · $3.535M66.83% · $10.32MUnavailable100% · $15.442M
FY 2012 Q48.23% · $1.133MUnavailable16.83% · $2.315M74.94% · $10.311MUnavailable100% · $13.759M
FY 2013 Q119.61% · $2.515M0% · $0M0% · $0M80.39% · $10.312MUnavailable100% · $12.827M
FY 2013 Q242.66% · $8.22M0% · $0M0% · $0M57.34% · $11.048MUnavailable100% · $19.268M
FY 2013 Q336.57% · $6.373M0% · $0M0% · $0M63.43% · $11.053MUnavailable100% · $17.426M
FY 2013 Q429.35% · $5.346M0% · $0M10% · $1.821M60.66% · $11.05MUnavailable100% · $18.217M
FY 2014 Q13.23% · $3.811M87.4% · $103.049MUnavailable9.37% · $11.051MUnavailable100% · $117.911M
FY 2014 Q224.02% · $3.647M0.66% · $0.1MUnavailable75.32% · $11.434MUnavailable100% · $15.181M
FY 2014 Q327.14% · $4.261M0% · $0MUnavailable72.86% · $11.44MUnavailable100% · $15.701M
FY 2014 Q410.72% · $2.102M30.77% · $6.031MUnavailable58.51% · $11.469MUnavailable100% · $19.602M
FY 2015 Q11.3% · $4.905M95.65% · $360.175MUnavailable3.05% · $11.472MUnavailable100% · $376.552M
FY 2015 Q24.19% · $3.142M79.98% · $59.927MUnavailable15.83% · $11.863MUnavailable100% · $74.932M
FY 2015 Q329.3% · $4.924M0% · $0MUnavailable70.7% · $11.883MUnavailable100% · $16.807M
FY 2015 Q436.84% · $6.934M0% · $0MUnavailable63.16% · $11.888MUnavailable100% · $18.822M
FY 2016 Q16.06% · $6.121M82.16% · $82.97MUnavailable11.78% · $11.894MUnavailable100% · $100.985M
FY 2016 Q229.11% · $4.887MUnavailableUnavailable70.89% · $11.902MUnavailable100% · $16.789M
FY 2016 Q312.47% · $2.836M35.18% · $8MUnavailable52.34% · $11.902MUnavailable100% · $22.738M
FY 2016 Q419.71% · $3.054M3.45% · $0.535MUnavailable76.84% · $11.909MUnavailable100% · $15.498M
FY 2017 Q10.89% · $2.442M94.74% · $259.004MUnavailable4.36% · $11.932MUnavailable100% · $273.378M
FY 2017 Q219.29% · $2.853MUnavailableUnavailable80.71% · $11.939MUnavailable100% · $14.792M
FY 2017 Q325.16% · $4.016MUnavailableUnavailable74.84% · $11.943MUnavailable100% · $15.959M
FY 2017 Q433.76% · $5.868MUnavailableUnavailable66.24% · $11.511MUnavailable100% · $17.379M
FY 2018 Q115.57% · $5.273M31.4% · $10.634MUnavailable35.31% · $11.958M17.72% · $6M100% · $33.865M
FY 2018 Q234.56% · $6.335M0.05% · $0.01MUnavailable65.39% · $11.988MUnavailable100% · $18.333M
FY 2018 Q35.02% · $3.508M77.83% · $54.422MUnavailable17.15% · $11.995MUnavailable100% · $69.925M
FY 2018 Q428.19% · $5.818M13.5% · $2.785MUnavailable58.31% · $12.032MUnavailable100% · $20.635M
FY 2019 Q10.65% · $4.19M42.17% · $272.229MUnavailable1.87% · $12.066M55.32% · $357.125M100% · $645.61M
FY 2019 Q227.49% · $4.604M0.35% · $0.058MUnavailable72.16% · $12.085MUnavailable100% · $16.747M
FY 2019 Q328.95% · $4.925MUnavailable0.01% · $0.001M71.04% · $12.086MUnavailable100% · $17.012M
FY 2019 Q428.5% · $11.692M41.94% · $17.206M0% · $0M29.56% · $12.127MUnavailable100% · $41.025M
FY 2020 Q146.38% · $10.525M0% · $0MUnavailable53.62% · $12.169MUnavailable100% · $22.694M
FY 2020 Q254.42% · $14.564M0% · $0MUnavailable45.58% · $12.196MUnavailable100% · $26.76M
FY 2020 Q312.95% · $9.282M0% · $0M69.92% · $50.112M17.13% · $12.279MUnavailable100% · $71.673M
FY 2020 Q458.63% · $17.373M0% · $0M0% · $0M41.37% · $12.258MUnavailable100% · $29.631M
FY 2021 Q147% · $10.938MUnavailableUnavailable53% · $12.336MUnavailable100% · $23.274M
FY 2021 Q248.01% · $11.445MUnavailableUnavailable51.99% · $12.392MUnavailable100% · $23.837M
FY 2021 Q316.01% · $10.602M0% · $0M65.2% · $43.178M18.79% · $12.446MUnavailable100% · $66.226M
FY 2021 Q44.73% · $11.316M90.07% · $215.587M0% · $0M5.2% · $12.448MUnavailable100% · $239.351M
FY 2022 Q132.7% · $6.07MUnavailableUnavailable67.3% · $12.493MUnavailable100% · $18.563M
FY 2022 Q244.71% · $10.168MUnavailableUnavailable55.29% · $12.576MUnavailable100% · $22.744M
FY 2022 Q317.06% · $15.1MUnavailable68.73% · $60.838M14.21% · $12.577MUnavailable100% · $88.515M
FY 2022 Q415.98% · $13.57MUnavailable69.26% · $58.818M14.76% · $12.539MUnavailable100% · $84.927M
FY 2023 Q16.69% · $9.556M70.83% · $101.184M13.69% · $19.562M8.78% · $12.545MUnavailable100% · $142.847M
FY 2023 Q232.72% · $6.109M0% · $0M0% · $0M67.28% · $12.561MUnavailable100% · $18.67M
FY 2023 Q348.29% · $11.748M0% · $0M0% · $0M51.71% · $12.582MUnavailable100% · $24.33M
FY 2023 Q446.23% · $10.831M0% · $0M0% · $0M53.77% · $12.597MUnavailable100% · $23.428M
FY 2024 Q17.05% · $13.592M86.38% · $166.426MUnavailable6.57% · $12.654MUnavailable100% · $192.672M
FY 2024 Q248.41% · $14.864M10.69% · $3.281MUnavailable40.9% · $12.559MUnavailable100% · $30.704M
FY 2024 Q356.65% · $16.441M0% · $0M0% · $0M43.35% · $12.579MUnavailable100% · $29.02M
FY 2024 Q458.74% · $17.98M0% · $0M0% · $0M41.26% · $12.627MUnavailable100% · $30.607M
FY 2025 Q141.96% · $9.172MUnavailableUnavailable58.04% · $12.688MUnavailable100% · $21.86M
FY 2025 Q234.88% · $6.821MUnavailableUnavailable65.12% · $12.736MUnavailable100% · $19.557M
FY 2025 Q38.25% · $10.123M0% · $0M81.5% · $100.046M10.25% · $12.58MUnavailable100% · $122.749M
FY 2025 Q44.17% · $4.89MUnavailable85.28% · $100.057M10.56% · $12.387MUnavailable100% · $117.334M
FY 2026 Q130.08% · $5.363MUnavailable0.13% · $0.024M69.79% · $12.444MUnavailable100% · $17.831M
FY 2026 Q232.2% · $5.921MUnavailable0% · $0M67.8% · $12.47MUnavailable100% · $18.391M
FY 2026 Q342.06% · $9.086MUnavailable0% · $0M57.94% · $12.518MUnavailable100% · $21.604M
FY 2026 Q413.54% · $8.48MUnavailable66.52% · $41.651M19.94% · $12.484MUnavailable100% · $62.615M
Sep 30, 2010 through Jun 30, 2026

Operating cash flow

USD millions

$95.416M

Capital expenditures

USD millions

$8.48M

Free cash flow

USD millions

$86.936M

Stock-based compensation

USD millions

$5.23M

SBC / free cash flow

% · FCF before SBC deduction

6.02%

SBC / operating cash flow

%

5.48%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

—

Quarterly data

Bio-Techne cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q4Jun 30, 202695.428.4886.945.236.02%5.48%——
FY 2026 Q3Mar 31, 202686.669.0977.5810.513.53%12.11%—$0.32
FY 2026 Q2Dec 31, 202582.415.9276.4913.9618.25%16.94%—$0.24
FY 2026 Q1Sep 30, 202527.595.3622.2211.6852.57%42.35%—$0.24
FY 2025 Q4Jun 30, 202598.24.8993.314.554.88%4.63%——
FY 2025 Q3Mar 31, 202541.1210.123111.3936.75%27.7%—$0.14
FY 2025 Q2Dec 31, 202484.356.8277.5314.7118.97%17.44%—$0.22
FY 2025 Q1Sep 30, 202463.899.1754.7210.1818.61%15.94%—$0.21
FY 2024 Q4Jun 30, 202475.517.9857.527.0612.28%9.36%——
FY 2024 Q3Mar 31, 202480.9916.4464.558.1312.6%10.04%—$0.31
FY 2024 Q2Dec 31, 202383.1214.8668.2512.7518.69%15.34%—$0.17
FY 2024 Q1Sep 30, 202359.3813.5945.7910.0922.04%17%—$0.31
FY 2023 Q4Jun 30, 202383.3910.8372.56-2.09-2.87%-2.5%——
FY 2023 Q3Mar 31, 202350.5411.7538.7910.1126.07%20.01%—$0.43
FY 2023 Q2Dec 31, 202264.386.1158.2816.7428.73%26.01%—$0.31
FY 2023 Q1Sep 30, 202256.089.5646.5314.4631.08%25.79%—$0.55
FY 2022 Q4Jun 30, 2022102.7213.5789.158.419.43%8.18%——
FY 2022 Q3Mar 31, 202273.1315.158.038.0713.91%11.04%—$0.37
FY 2022 Q2Dec 31, 2021100.9910.1790.8213.9715.38%13.83%—$0.49
FY 2022 Q1Sep 30, 202148.436.0742.3611.7427.71%24.23%—$0.42
FY 2021 Q4Jun 30, 2021122.0211.32110.79.818.86%8.04%——
FY 2021 Q3Mar 31, 202174.8710.664.2610.6416.56%14.22%—$0.28
FY 2021 Q2Dec 31, 202089.2711.4577.8215.5820.02%17.45%—$0.29
FY 2021 Q1Sep 30, 202066.0110.9455.0712.9523.52%19.62%—$0.21
FY 2020 Q4Jun 30, 202044.7917.3727.426.0221.95%13.43%—$0.37
FY 2020 Q3Mar 31, 202049.479.2840.197.8619.55%15.88%—$0.23
FY 2020 Q2Dec 31, 201970.4214.5655.8510.1318.13%14.38%—$0.76
FY 2020 Q1Sep 30, 201940.5410.5330.018.3727.87%20.64%—$0.09
FY 2019 Q4Jun 30, 201955.9511.6944.258.1318.37%14.53%—$0.11
FY 2019 Q3Mar 31, 201939.664.9334.745.7316.48%14.43%—$0.29
FY 2019 Q2Dec 31, 201846.564.641.966.8616.35%14.73%—$0.11
FY 2019 Q1Sep 30, 201839.454.1935.2611.5732.8%29.32%—$0.11
FY 2018 Q4Jun 30, 201864.845.8259.0214.6524.83%22.6%—$0.27
FY 2018 Q3Mar 31, 201821.653.5118.144.7526.17%21.93%—$0.13
FY 2018 Q2Dec 31, 201739.186.3432.855.0415.36%12.87%—$0.32
FY 2018 Q1Sep 30, 201744.75.2739.423.89.63%8.49%—$0.11
FY 2017 Q4Jun 30, 201750.835.8744.963.417.59%6.71%—$0.19
FY 2017 Q3Mar 31, 201724.944.0220.923.9718.99%15.93%—$0.14
FY 2017 Q2Dec 31, 201641.182.8538.334.0610.58%9.85%—$0.04
FY 2017 Q1Sep 30, 201626.52.4424.063.1813.2%11.98%—$0.11
FY 2016 Q4Jun 30, 201636.363.0533.312.758.27%7.57%—$0.17
FY 2016 Q3Mar 31, 201637.142.8434.32.326.75%6.24%—$0.2
FY 2016 Q2Dec 31, 201538.544.8933.652.326.9%6.02%—$0.17
FY 2016 Q1Sep 30, 201531.836.1225.712.047.93%6.4%—$0.15
FY 2015 Q4Jun 30, 201537.146.9330.211.234.08%3.32%——
FY 2015 Q3Mar 31, 201530.784.9225.851.294.98%4.19%—$0.16
FY 2015 Q2Dec 31, 201435.733.1432.582.086.37%5.81%—$0.22
FY 2015 Q1Sep 30, 201435.724.9130.811.364.42%3.81%—$0.16
FY 2014 Q4Jun 30, 201437.922.135.820.892.48%2.34%——
FY 2014 Q3Mar 31, 201434.934.2630.670.742.41%2.12%—$0.21
FY 2014 Q2Dec 31, 201331.323.6527.68————$0.17
FY 2014 Q1Sep 30, 201332.593.8128.77————$0.19
FY 2013 Q4Jun 30, 201329.995.3524.64—————
FY 2013 Q3Mar 31, 201333.036.3726.65————$0.23
FY 2013 Q2Dec 31, 201231.298.2223.07————$0.17
FY 2013 Q1Sep 30, 201229.262.5226.75————$0.18
FY 2012 Q4Jun 30, 201237.411.1336.28—————
FY 2012 Q3Mar 31, 201234.461.5932.88————$0.22
FY 2012 Q2Dec 31, 201120.442.218.24————$0.18
FY 2012 Q1Sep 30, 201134.431.133.34————$0.19
FY 2011 Q4Jun 30, 201134.671.2733.4—————
FY 2011 Q3Mar 31, 201132.390.5931.79————$0.21
FY 2011 Q2Dec 31, 201029.430.7128.72————$0.18
FY 2011 Q1Sep 30, 201030.71.0529.65————$0.18
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · TECH, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.